These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 28656780)

  • 1. Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation.
    Lusthaus JA; Goldberg I
    Expert Opin Drug Saf; 2017 Sep; 16(9):1071-1078. PubMed ID: 28656780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of brinzolamide/brimonidine versus brinzolamide plus brimonidine for open-angle glaucoma or ocular hypertension.
    Gandolfi SA; Lim J; Sanseau AC; Parra Restrepo JC; Hamacher T
    Adv Ther; 2014 Dec; 31(12):1213-27. PubMed ID: 25430900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twice-daily brinzolamide/brimonidine fixed combination versus brinzolamide or brimonidine in open-angle glaucoma or ocular hypertension.
    Aung T; Laganovska G; Hernandez Paredes TJ; Branch JD; Tsorbatzoglou A; Goldberg I
    Ophthalmology; 2014 Dec; 121(12):2348-55. PubMed ID: 25064721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.
    Katz G; Dubiner H; Samples J; Vold S; Sall K
    JAMA Ophthalmol; 2013 Jun; 131(6):724-30. PubMed ID: 23579344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brinzolamide/brimonidine: a review of its use in patients with open-angle glaucoma or ocular hypertension.
    Greig SL; Deeks ED
    Drugs Aging; 2015 Mar; 32(3):251-60. PubMed ID: 25732405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension.
    Day DG; Hollander DA
    Curr Med Res Opin; 2008 May; 24(5):1435-42. PubMed ID: 18402717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase 3 randomized 3-month trial with an ongoing 3-month safety extension of fixed-combination brinzolamide 1%/brimonidine 0.2%.
    Nguyen QH; McMenemy MG; Realini T; Whitson JT; Goode SM
    J Ocul Pharmacol Ther; 2013 Apr; 29(3):290-7. PubMed ID: 23425430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-life experience of using brinzolamide/brimonidine fixed drop combination in a tertiary glaucoma centre.
    Kóthy P; Holló G
    Int Ophthalmol; 2020 Feb; 40(2):377-383. PubMed ID: 31650353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy and Safety of the Fixed Combination of Brinzolamide 1% and Brimonidine 0.2% in Normal Tension Glaucoma: An 18-Month Retrospective Study.
    Jin SW; Lee SM
    J Ocul Pharmacol Ther; 2018 Apr; 34(3):274-279. PubMed ID: 29297751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of allergy prevalence using brinzolamide 1.0% / brimonidine 0.2% fixed combination with and without β-blocker in glaucoma patients: a retrospective cohort study.
    Park IK; Bae SH; Jeong JH; Kim KW; Yi K; Chun YS
    BMC Ophthalmol; 2024 Jul; 24(1):281. PubMed ID: 38992579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brinzolamide plus brimonidine for the treatment of glaucoma: an update.
    Chew SK; Skalicky SE; Goldberg I
    Expert Opin Pharmacother; 2014 Nov; 15(16):2461-71. PubMed ID: 25267543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brinzolamide/brimonidine fixed-dose combination bid as an adjunct to a prostaglandin analog for open-angle glaucoma/ocular hypertension.
    Topouzis F; Goldberg I; Bell K; Tatham AJ; Ridolfi A; Hubatsch D; Nicolela M; Denis P; Lerner SF
    Eur J Ophthalmol; 2021 Jan; 31(1):103-111. PubMed ID: 31595773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed-combination brinzolamide 1%/brimonidine 0.2% vs monotherapy with brinzolamide or brimonidine in patients with open-angle glaucoma or ocular hypertension: results of a pooled analysis of two phase 3 studies.
    Realini T; Nguyen QH; Katz G; DuBiner H
    Eye (Lond); 2013 Jul; 27(7):841-7. PubMed ID: 23640612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
    Bournias TE; Lai J
    Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the ocular hypotensive efficacy of adjunctive brimonidine 0.15% or brinzolamide 1% in combination with travoprost 0.004%.
    Feldman RM; Tanna AP; Gross RL; Chuang AZ; Baker L; Reynolds A; Prager TC;
    Ophthalmology; 2007 Jul; 114(7):1248-54. PubMed ID: 17509688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brinzolamide 1%/timolol 0.5%: safety and efficacy of a new fixed-combination IOP-lowering product for glaucoma.
    Januleviciene I
    Curr Med Res Opin; 2010 Nov; 26(11):2575-8. PubMed ID: 20868340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Use of Brinzolamide-Brimonidine Fixed Combination in Maximum Medical Therapy.
    Tekeli O; Köse HC
    Turk J Ophthalmol; 2022 Aug; 52(4):262-269. PubMed ID: 36017234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Sezgin Akçay Bİ; Güney E; Bozkurt KT; Unlü C; Akçali G
    J Ocul Pharmacol Ther; 2013 Dec; 29(10):882-6. PubMed ID: 24180628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brinzolamide/timolol fixed combination: a new ocular suspension for the treatment of open-angle glaucoma and ocular hypertension.
    Holló G; Bozkurt B; Irkec M
    Expert Opin Pharmacother; 2009 Aug; 10(12):2015-24. PubMed ID: 19618994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.